Dolby Laboratories, Inc.DLBNYSE
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank54
3Y CAGR-64.8%
5Y CAGR-54.2%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-64.8%/yr
vs +138.9%/yr prior
5Y CAGR
-54.2%/yr
Recent deceleration
Acceleration
-203.7pp
Decelerating
Percentile
P54
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 8.10% |
| Q3 2025 | 7.08% |
| Q2 2025 | -49.81% |
| Q1 2025 | 35.34% |
| Q4 2024 | 15.80% |
| Q3 2024 | 52.35% |
| Q2 2024 | -60.70% |
| Q1 2024 | 46.06% |
| Q4 2023 | 629.16% |
| Q3 2023 | -43.98% |
| Q2 2023 | -82.86% |
| Q1 2023 | 20.56% |
| Q4 2022 | 185.97% |
| Q3 2022 | -29.90% |
| Q3 2022 | 7.83% |
| Q2 2022 | -54.11% |
| Q4 2021 | 81.06% |
| Q3 2021 | -19.10% |
| Q2 2021 | -28.33% |
| Q1 2021 | -43.63% |
| Q4 2020 | 403.92% |
| Q3 2020 | -60.13% |
| Q2 2020 | -23.97% |
| Q1 2020 | 81.52% |
| Q4 2019 | 11.01% |
| Q3 2019 | 10.98% |
| Q2 2019 | -46.11% |
| Q1 2019 | -25.23% |
| Q4 2018 | 267.64% |
| Q3 2018 | 757.38% |
| Q2 2018 | -95.22% |
| Q1 2018 | 222.35% |
| Q4 2017 | -344.56% |
| Q3 2017 | -71.34% |
| Q2 2017 | 50.31% |
| Q1 2017 | -5.22% |
| Q4 2016 | 123.01% |
| Q3 2016 | -62.39% |
| Q3 2016 | -5.59% |
| Q2 2016 | 118.11% |